To include your compound in the COVID-19 Resource Center, submit it here.

Former Allergan execs join Merck spinout; plus Ping An ousts Tao, and updates from Mirati, Evox, Ardelyx, Akcea, Horama and more

Merck & Co. Inc. (NYSE:MRK) hired Matthew Walsh as CFO and Rachel Stahler as chief information officer of its planned spinout Organon & Co. Walsh was EVP and CFO of Allergan plc, which was acquired by AbbVie Inc. (NYSE:ABBV) in May,

Read the full 419 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers